IL21 and rheumatoid arthritis: In rheumatoid arthritis (RA) patients, IL-21 has been found to impair the pro-inflammatory activity of M1-like macrophages in synovial fluid and to inhibit LPS-induced secretion of inflammatory mediators by synovial fluid macrophages, thereby exerting anti-inflammatory effects (62).